13 participants
Haploid Allogeneic Transplant Using the CliniMACS System
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-03-09
- Start Date:
- 2001-11-30
- Completion:
- 2009-10-31
Conditions
- Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors
- Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase
- Myelodysplastic Syndrome (MDS) - High and Intermediate Risk
- Non-Hodgkin's Lymphoma (NHL)
- Chronic Lymphocytic Leukemia (CLL) - Refractory
Interventions
- DEVICE